Pioneer ACO Quality Outcomes
Atrius Health Pioneer Accountable Care Organization (ACO) Performance
Each of the organizations that was competitively selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Pioneer Accountable Care Organization (ACO) is required to demonstrate it has met the quality standards each year it participates. Each specific outcome can be seen in the table below:
| Measure Number |
Measure |
Atrius Health 2014 |
Pioneer ACO Mean |
|
Domain: Patient and Caregiver Experience |
|||
| ACO-1 |
Getting Timely Care, Appointments, and Information |
89.06% |
81.95% |
| ACO-2 |
How Well Your Doctors Communicate |
95.45% |
92.99% |
| ACO-3 |
Patients' Rating of Doctor |
94.18% |
92.41% |
| ACO-4 |
Access to Specialists |
84.06% |
83.93% |
| ACO-5 |
Health Promotion and Education |
62.96% |
60.15% |
| ACO-6 |
Shared Decision Making |
76.31% |
74.63% |
| ACO-7 |
Health Status/Functional Status |
74.52% |
72.32% |
|
Domain: Care Coordination/Patient Safety |
|||
| ACO-8 |
Risk Standardized, All Condition Readmissions (lower scores are better) |
15.81 |
15.3 |
| ACO-9 |
ASC Admissions: COPD or Asthma in Older Adults (lower scores are better) |
1.08 |
1.06 |
| ACO-10 |
ASC Admissions: Heart Failure (lower scores are better) |
1.23 |
1.11 |
| ACO-11 |
Percent of PCPs who Qualified for EHR Incentive Payment |
98.16% |
86.13% |
| ACO-12 |
Medication Reconciliation |
84.30% |
83.56% |
| ACO-13 |
Falls: Screening for Fall Risk |
94.60% |
64.61% |
|
Domain: Preventive Health |
|||
| ACO-14 |
Influenza Immunization |
85.51% |
70.56% |
| ACO-15 |
Pneumococcal Vaccination |
91.49% |
77.00% |
| ACO-16 |
Adult Weight Screening and Follow-up |
73.19% |
67.90% |
| ACO-17 |
Tobacco Use Assessment and Cessation Intervention |
98.53% |
93.70% |
| ACO-18 |
Depression Screening |
90.75% |
59.67% |
| ACO-19 |
Colorectal Cancer Screening |
86.60% |
74.46% |
| ACO-20 |
Mammography Screening |
92.82% |
76.02% |
| ACO-21 |
Proportion of Adults who had blood pressure screened in past 2 years |
45.18% |
56.23% |
|
Domain: At Risk Population - Diabetes |
|||
| Diabetes Composite |
Percent of patients with diabetes who met all of the following criteria: |
54.52% |
36.77% |
| ACO-22 |
Hemoglobin A1c Control (HbA1c) (<8 percent) |
79.97% |
75.23% |
| ACO-23 |
Low Density Lipoprotein (LDL) (<100mg/dL) |
83.74% |
67.22% |
| ACO-24 |
Blood Pressure (BP) <140/90 |
86.21% |
78.58% |
| ACO-25 |
Tobacco Non-Use |
89.00% |
82.30% |
| ACO-26 |
Aspirin Use |
91.52% |
88.22% |
| ACO-27 |
Percent of patients with diabetes whose HbA1c in poor control (>9 percent) (lower scores are better) |
9.52% |
14.11% |
|
Domain: At Risk Population - Hypertension |
|||
| ACO-28 |
Percent of patients with hypertension whose BP < 140/90 |
79.28% |
74.98% |
|
Domain: At Risk Population - Ischemic Vascular Disease (IVD) |
|||
| ACO-29 |
Percent of patients with IVD with complete lipid profile and LDL control <100mg/dl |
74.88% |
65.40% |
| ACO-30 |
Percent of patients who use Aspirin or other antithrombotic |
88.10% |
87.68% |
|
Domain: At Risk Population - Heart Failure |
|||
| ACO-31 |
Beta-Blocker Therapy for LVSD |
97.83% |
88.82% |
|
Domain: At Risk Population - Coronary Artery Disease (CAD) |
|||
| CAD Composite |
Percent of patients with CAD who met all of the following criteria: |
88.41% |
73.59% |
| ACO-32 |
Drug Therapy for Lowering LDL-Cholesterol |
94.59% |
78.74% |
| ACO-33 |
ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD |
88.50% |
81.01% |
